ProfileGDS4718 / 204929_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 74% 76% 84% 75% 68% 68% 69% 71% 80% 68% 73% 78% 76% 67% 75% 72% 69% 75% 60% 77% 70% 74% 75% 75% 72% 70% 74% 67% 69% 62% 64% 77% 71% 75% 67% 75% 61% 74% 73% 88% 77% 66% 73% 69% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1893974
GSM549102patient 115, normal, homogenized [OPG study]7.3543576
GSM549104patient 119, normal, homogenized [OPG study]8.3891484
GSM549108patient 138, normal, homogenized [OPG study]7.2418475
GSM549119patient 077, normal, homogenized [OPG study]6.6971868
GSM549133patient 032, cancer, homogenized [OPG study]6.7857468
GSM549139patient 042, cancer, homogenized [OPG study]6.8313669
GSM549099patient 107, normal, homogenized [OPG study]6.8703871
GSM549109patient 139, normal, homogenized [OPG study]7.792180
GSM549110patient 046, normal, homogenized [OPG study]6.6977968
GSM549114patient 063, normal, homogenized [OPG study]7.1905473
GSM549122patient 082, normal, homogenized [OPG study]7.5968878
GSM549134patient 033, cancer, homogenized [OPG study]7.4350576
GSM549136patient 036, cancer, homogenized [OPG study]6.6702667
GSM549140patient 044, cancer, homogenized [OPG study]7.3954675
GSM549111patient 047, normal, homogenized [OPG study]7.0538172
GSM549113patient 057, normal, homogenized [OPG study]6.824369
GSM549132patient 031, cancer, homogenized [OPG study]7.3120375
GSM549137patient 038, cancer, homogenized [OPG study]6.1053960
GSM549142patient 047, cancer, homogenized [OPG study]7.3709577
GSM549100patient 110, normal, homogenized [OPG study]6.8295370
GSM549107patient 135, normal, homogenized [OPG study]7.2639674
GSM549115patient 068, normal, homogenized [OPG study]7.4494775
GSM549116patient 072, normal, homogenized [OPG study]7.3621275
GSM549120patient 078, normal, homogenized [OPG study]7.0165272
GSM549131patient 030, cancer, homogenized [OPG study]6.9720170
GSM549118patient 074, normal, homogenized [OPG study]7.2060774
GSM549129patient 027, cancer, homogenized [OPG study]6.657767
GSM549123patient 088, normal, homogenized [OPG study]6.7820169
GSM549124patient 006, cancer, homogenized [OPG study]6.2806962
GSM549126patient 015, cancer, homogenized [OPG study]6.3987764
GSM549128patient 025, cancer, homogenized [OPG study]7.629177
GSM549103patient 117, normal, homogenized [OPG study]6.8587571
GSM549117patient 073, normal, homogenized [OPG study]7.2801375
GSM549138patient 041, cancer, homogenized [OPG study]6.6728467
GSM549141patient 045, cancer, homogenized [OPG study]7.489475
GSM549130patient 028, cancer, homogenized [OPG study]6.1766261
GSM549101patient 111, normal, homogenized [OPG study]7.2327974
GSM549105patient 128, normal, homogenized [OPG study]7.0929773
GSM549106patient 134, normal, homogenized [OPG study]9.0750188
GSM549112patient 048, normal, homogenized [OPG study]7.5330677
GSM549125patient 011, cancer, homogenized [OPG study]6.5437566
GSM549127patient 024, cancer, homogenized [OPG study]7.2132973
GSM549135patient 035, cancer, homogenized [OPG study]6.8794769